Single arm phase II trial assessing the safety, compliance with and activity of Bezafibrate and medroxyProgesterone acetate (BaP) therapy against myeloid and lymphoid cancers

Autor: Murray, Jim, Pratt, Guy, Jacob, Abe, Clark, Fiona, Blundred, Rachel, Fox, Sonia, Bishop, Rebecca, Wheatley, Keith, Khanim, Farhat, Bunce, Chris, Drayson, Mark
Zdroj: In Contemporary Clinical Trials Communications June 2019 14
Databáze: ScienceDirect